Literatur
- 1
Appel L J, Moore T J, Obarzanek E. et al. for the DASH Collaborative Research Group
.
A clinical trial of the effects of dietary patterns on blood pressure.
N Engl J Med.
1997;
336
1117-1124
- 2
Dahlöf B, Sever P S, Poulter N R. et al .
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine
adding perindopril as required versus atenolol adding bendroflumethiazide as required,
in the Anglo-Scandinavian Cardiac OutcomesTrial - Blood Pressure Lowering Arm (ASCOT-BPLA):
a multicentre randomised controlled trial.
Lancet.
2005;
366
895-906
- 3
Dahlöf B. et al .
Conduit Artery Function Evaluation.
Lancet.
2005;
366
895-906
- 4
Franklin S S, Pio J R, Wong N D. et al .
Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart
Study.
Circulation.
2005;
111
1121-1127
- 5
Julius S t, Nesbitt S D, Egan B M. et al .
Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker.
Engl J Med.
2006;
354
1685-1697
- 6
Lindholm L H, Carlberg B, Samuelsson O.
Should b blockers remain first choice in the treatment of primary hypertension? A
meta-analysis.
Lancet.
2005;
366
1545-1553
- 7
Poulter N R, Wedel H, Dahlöf B. et al .
Role of blood pressure and other variables in the differential cardiovascular event
rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering
Arm (ASCOT-BPLA).
Lancet.
2005;
366
907-913
- 8
Staessen J A, Birkenhager W H.
Evidence that new antihypertensives are superior to older drugs.
Lancet.
2005;
366
869-871
- 9
Svetkey L P.
Management of prehypertension.
Hypertension.
2005;
45
1056-1061
- 10
Vasan R S, Larson M G, Leip E P. et al .
Impact of high-normal blood pressure on the risk of cardiovascular disease.
Engl J Med.
2001;
345
1291-1297
Prof. Dr. med. Martin Middeke
Blutdruckinstitut München
Osterwaldstraße 69
80805 München
Phone: 089/36103947
Fax: 089/36104026
Email: info@blutdruckinstitut.de
